280 related articles for article (PubMed ID: 19770405)
1. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.
Fagard RH; Celis H; Thijs L; Wouters S
Hypertension; 2009 Nov; 54(5):1084-91. PubMed ID: 19770405
[TBL] [Abstract][Full Text] [Related]
2. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
Schmieder RE; Martus P; Klingbeil A
JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
[TBL] [Abstract][Full Text] [Related]
4. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
5. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of the combined treatment efficacy of the Chernobyl accident clean-up workers with essential hypertension].
Habulavichene ZhM
Lik Sprava; 2012 Dec; (8):21-9. PubMed ID: 23786006
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
8. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
Schmieder RE; Schlaich MP
Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
[TBL] [Abstract][Full Text] [Related]
9. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of left ventricular hypertrophy by antihypertensive drugs.
Fagard RH
Neth J Med; 1995 Oct; 47(4):173-9. PubMed ID: 8538821
[TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
Dahlöf B
Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
[TBL] [Abstract][Full Text] [Related]
12. [Left Ventricular Hypertrophy in Hypertension. Part III. Reversibility of Left Ventricular Hypertrophy During Treatment With Antihypertensive Drugs].
Preobrazhenskiĭ DV; Sidorenko BA; Alekhin MN; Batyraliev TA; Stetsenko TM
Kardiologiia; 2004; 44(4):89-94. PubMed ID: 15111978
[TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
[TBL] [Abstract][Full Text] [Related]
14. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
[No Abstract] [Full Text] [Related]
16. Longitudinal change in left ventricular hypertrophy in the elderly on antihypertensive therapy.
Ahmad A; Nawaz HM; Nevins L; Nawaz H
Conn Med; 2003 Feb; 67(2):67-73. PubMed ID: 12664833
[TBL] [Abstract][Full Text] [Related]
17. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Jul; 33(7):1321-41. PubMed ID: 26039526
[TBL] [Abstract][Full Text] [Related]
18. [Management of hypertensive patients with cardiovascular damage].
Tomiyama H; Takata Y; Yamashina A
Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
[No Abstract] [Full Text] [Related]
19. Real role of β-blockers in regression of left ventricular mass in hypertension patients: Bayesian network meta-analysis.
Xing F; Chen J; Zhao B; Jiang J; Tang A; Chen Y
Medicine (Baltimore); 2017 Mar; 96(10):e6290. PubMed ID: 28272254
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension.
Reichek N; Devereux RB; Rocha RA; Hilkert R; Hall D; Purkayastha D; Pitt B
Hypertension; 2009 Oct; 54(4):731-7. PubMed ID: 19687350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
